Serum cystatin C level, kidney disease markers, and incidence of age-related macular degeneration: the Beaver Dam Eye Study.
暂无分享,去创建一个
[1] R. Klein,et al. The Wisconsin age-related maculopathy grading system. , 1991, Ophthalmology.
[2] U. Felbor,et al. Generation and degradation of human endostatin proteins by various proteinases , 2000, FEBS letters.
[3] R. Klein,et al. Changes in visual acuity in a population over a 10-year period : The Beaver Dam Eye Study. , 2001, Ophthalmology.
[4] R. Klein,et al. Changes in visual acuity in a population. The Beaver Dam Eye Study. , 1996, Ophthalmology.
[5] R. Klein,et al. Complement factor H and hemicentin-1 in age-related macular degeneration and renal phenotypes. , 2007, Human molecular genetics.
[6] A. Barrett,et al. Isolation of six cysteine proteinase inhibitors from human urine. Their physicochemical and enzyme kinetic properties and concentrations in biological fluids. , 1986, The Journal of biological chemistry.
[7] M. Blumenkranz,et al. Risk factors in age-related maculopathy complicated by choroidal neovascularization. , 1986, Ophthalmology.
[8] Ethan M Balk,et al. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[9] E. Im,et al. Cathepsin B regulates the intrinsic angiogenic threshold of endothelial cells. , 2005, Molecular biology of the cell.
[10] J. Alexander,et al. Mouse podocyte complement factor H: the functional analog to human complement receptor 1. , 2007, Journal of the American Society of Nephrology : JASN.
[11] J. Wassélius,et al. Identification and localization of retinal cystatin C. , 2001, Investigative ophthalmology & visual science.
[12] W. Bode,et al. cystatins: protein inhibitors of cysteine proteinases , 2001 .
[13] D. Spiegelman,et al. Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. , 2004, Kidney international.
[14] Ronald Klein,et al. Changes in visual acuity in a population over a 15-year period: the Beaver Dam Eye Study. , 2006, American journal of ophthalmology.
[15] T. Wienker,et al. The gene for human fibronectin glomerulopathy maps to 1q32, in the region of the regulation of complement activation gene cluster. , 1998, American journal of human genetics.
[16] M. Pericak-Vance,et al. Linkage of a gene causing familial membranoproliferative glomerulonephritis type III to chromosome 1. , 2002, Journal of the American Society of Nephrology : JASN.
[17] R. Klein,et al. Prevalence of age-related maculopathy. The Beaver Dam Eye Study. , 1992, Ophthalmology.
[18] C. Nordgaard,et al. Changes in select redox proteins of the retinal pigment epithelium in age-related macular degeneration. , 2007, American journal of ophthalmology.
[19] Y. Tsao,et al. Pigment epithelium-derived factor inhibits oxidative stress-induced cell death by activation of extracellular signal-regulated kinases in cultured retinal pigment epithelial cells. , 2006, Life Science.
[20] D. Pérez-Caballero,et al. Clustering of missense mutations in the C-terminal region of factor H in atypical hemolytic uremic syndrome. , 2001, American journal of human genetics.
[21] T. Shohat,et al. A locus for an autosomal dominant form of progressive renal failure and hypertension at chromosome 1q21. , 2000, American journal of human genetics.
[22] D. Levy,et al. Genomewide linkage analysis to serum creatinine, GFR, and creatinine clearance in a community-based population: the Framingham Heart Study. , 2004, Journal of the American Society of Nephrology : JASN.
[23] J. Morrow,et al. Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease. , 2004, Kidney international.
[24] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[25] A. Levey,et al. A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.
[26] Cm Taylor. Complement factor H and the haemolytic uraemic syndrome , 2001, The Lancet.
[27] T. Barka,et al. Expression of the cysteine proteinase inhibitor cystatin C mRNA in rat eye , 1994, The Anatomical record.
[28] Robert F Mullins,et al. A role for local inflammation in the formation of drusen in the aging eye. , 2002, American journal of ophthalmology.
[29] Robert F. Mullins,et al. An Integrated Hypothesis That Considers Drusen as Biomarkers of Immune-Mediated Processes at the RPE-Bruch's Membrane Interface in Aging and Age-Related Macular Degeneration , 2001, Progress in Retinal and Eye Research.
[30] H. Tsukaguchi,et al. A locus for adolescent and adult onset familial focal segmental glomerulosclerosis on chromosome 1q25-31. , 2000, Journal of the American Society of Nephrology : JASN.
[31] Tiansen Li,et al. Collagen XVIII/endostatin is essential for vision and retinal pigment epithelial function , 2004, The EMBO journal.
[32] R. Nitsch,et al. CST3 genotype associated with exudative age related macular degeneration , 2002, The British journal of ophthalmology.
[33] D. Hosmer,et al. Applied Logistic Regression , 1991 .
[34] I. Grierson,et al. Fate of cystatin C lacking the leader sequence in RPE cells. , 2003, Experimental eye research.
[35] S C Jensen,et al. Age-related maculopathy in a multiracial United States population: the National Health and Nutrition Examination Survey III. , 1999, Ophthalmology.
[36] Ronald Klein,et al. Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study. , 2007, Ophthalmology.
[37] Usha Chakravarthy,et al. Prevalence of age related maculopathy in northern India , 2004 .
[38] Cockcroft Dw,et al. Prediction of Creatinine Clearance from Serum Creatinine , 1976 .
[39] R. Klein,et al. The Beaver Dam Eye Study: visual acuity. , 1991, Ophthalmology.
[40] R. Klein,et al. The validity of self-reported and surrogate-reported cataract and age-related macular degeneration in the Beaver Dam Eye Study. , 1991, American journal of epidemiology.
[41] Barrett Aj,et al. The cystatins: a diverse superfamily of cysteine peptidase inhibitors. , 1986, Biomedica biochimica acta.
[42] P. Mitchell,et al. CKD increases the risk of age-related macular degeneration. , 2008, Journal of the American Society of Nephrology : JASN.
[43] V. Sheffield,et al. Complement factor H gene mutation associated with autosomal recessive atypical hemolytic uremic syndrome. , 1999, American journal of human genetics.
[44] J. Alexander,et al. Complement factor h limits immune complex deposition and prevents inflammation and scarring in glomeruli of mice with chronic serum sickness. , 2004, Journal of the American Society of Nephrology : JASN.
[45] G. Deschênes,et al. Heterozygous and homozygous factor h deficiencies associated with hemolytic uremic syndrome or membranoproliferative glomerulonephritis: report and genetic analysis of 16 cases. , 2004, Journal of the American Society of Nephrology : JASN.
[46] D. Lenk,et al. Haemolytic uraemic syndrome and mutations of the factor H gene: a registry-based study of German speaking countries , 2003, Journal of medical genetics.
[47] R. Klein,et al. Ten-year incidence and progression of age-related maculopathy: The Beaver Dam eye study. , 2002, Ophthalmology.
[48] U. Felbor,et al. Collagen XVIII/endostatin structure and functional role in angiogenesis. , 2000, Cell structure and function.
[49] F. Leighton,et al. Inflammation, not hyperhomocysteinemia, is related to oxidative stress and hemostatic and endothelial dysfunction in uremia. , 2001, Kidney international.
[50] M. Landray,et al. Inflammation, endothelial dysfunction, and platelet activation in patients with chronic kidney disease: the chronic renal impairment in Birmingham (CRIB) study. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[51] A. Barrett. The cystatins: a diverse superfamily of cysteine peptidase inhibitors. , 1986, Biomedica biochimica acta.
[52] R. Klein,et al. Age-related eye disease, visual impairment, and survival: the Beaver Dam Eye Study. , 2005, Archives of ophthalmology.
[53] R. Sullivan,et al. Transporters and Oxidative Stress in AMD , 2005 .
[54] Kdoqi Disclaimer. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[55] P. Zipfel,et al. An interactive web database of factor H‐associated hemolytic uremic syndrome mutations: insights into the structural consequences of disease‐associated mutations , 2006, Human mutation.
[56] R. Klein,et al. The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study. , 1997, Ophthalmology.
[57] R. Klein,et al. Relation of smoking to the incidence of age-related maculopathy. The Beaver Dam Eye Study. , 1998, American journal of epidemiology.
[58] J L McRae,et al. Variations in the complement regulatory genes factor H (CFH) and factor H related 5 (CFHR5) are associated with membranoproliferative glomerulonephritis type II (dense deposit disease) , 2005, Journal of Medical Genetics.
[59] G. Filler,et al. Cystatin C as a marker of GFR--history, indications, and future research. , 2005, Clinical biochemistry.